Case reports reveal iron overload cardiomyopathy in cirrhosis, suggesting critical implications for diagnosis.
Iron overload cardiomyopathy (IOC) is a rare cause of heart failure classically associated with hereditary or transfusion-related hemochromatosis. Although iron accumulation occurs in cirrhosis, the development and clinical course of IOC in this population remain poorly described. We report 2 patients with cirrhosis who developed IOC without hereditary hemochromatosis or transfusion-dependent anemia. Patient #1 was a 54-year-old man with alcohol-associated cirrhosis who developed severe cardiomyopathy (left ventricular ejection fraction 23%, 55% 1 year earlier). Patient #2 was a 56-year-old man with cryptogenic cirrhosis who presented with new cardiomyopathy (left ventricular ejection fraction 38%, 71% 9 months earlier). Both patients had elevated ferritin and transferrin saturation, along with reduced myocardial T2∗ relaxation time on cardiac magnetic resonance imaging, consistent with IOC. Both received iron chelation therapy; one patient died, and the other is awaiting combined heart-liver transplantation. These cases highlight IOC as an important consideration in patients with cirrhosis presenting with new cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Nouraee et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: